➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Harvard Business School
McKesson
Dow
Colorcon

Last Updated: October 20, 2021

DrugPatentWatch Database Preview

ROBIMYCIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Robimycin, and what generic alternatives are available?

Robimycin is a drug marketed by Robins Ah and is included in one NDA.

The generic ingredient in ROBIMYCIN is erythromycin. There are one hundred and three drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Robimycin

A generic version of ROBIMYCIN was approved as erythromycin by TORRENT on July 6th, 2020.

  Free Forever Trial

US Patents and Regulatory Information for ROBIMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah ROBIMYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061633-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Harvard Business School
McKesson
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.